« Safety of Estrogen-Based Feminizing Gender-Affirming Hormone Therapy:  A Practical Endocrine Approach to Risk Stratification and Monitoring ». Canadian Diabetes & Endocrinology Today 4, no. 1 (mai 25, 2026): 10–16. Consulté le mai 26, 2026. https://CanadianDiabetesAndEndocrinologyToday.com/article/view/4-1-Kissock.